SUNPHARMAPharmaceuticals
Sun Pharmaceutical Industries Ltd — Cash Flow Statement
₹1757.20
+0.66%
Sun Pharmaceutical Industries Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 11.94K Cr | 9.93K Cr | 2.87K Cr | 7.49K Cr | — |
| Repurchase Of Capital Stock | -2.90K Cr | -77.39 Cr | 0.00 | -185.70 Cr | — |
| Repayment Of Debt | -4.34K Cr | -8.11K Cr | -2.90K Cr | -4.40K Cr | — |
| Issuance Of Debt | 3.36K Cr | 4.57K Cr | 8.16K Cr | 1.66K Cr | — |
| Capital Expenditure | -2.13K Cr | -2.20K Cr | -2.09K Cr | -1.50K Cr | — |
| End Cash Position | 10.27K Cr | 9.29K Cr | 4.62K Cr | 4.51K Cr | — |
| Other Cash Adjustment Outside Changein Cash | -0.03 Cr | 1.29 Cr | 566.69 Cr | 41.45 Cr | — |
| Beginning Cash Position | 9.29K Cr | 4.62K Cr | 4.51K Cr | 6.27K Cr | — |
| Effect Of Exchange Rate Changes | 123.04 Cr | -73.99 Cr | 157.07 Cr | 127.43 Cr | — |
| Changes In Cash | 860.11 Cr | 4.73K Cr | -608.28 Cr | -1.93K Cr | — |
| Financing Cash Flow | -7.91K Cr | -6.71K Cr | 2.38K Cr | -5.19K Cr | — |
| Interest Paid Cff | -223.82 Cr | -219.03 Cr | -132.48 Cr | -73.21 Cr | — |
| Cash Dividends Paid | -3.61K Cr | -2.90K Cr | -2.52K Cr | -2.16K Cr | — |
| Net Common Stock Issuance | -2.90K Cr | -77.39 Cr | 0.00 | -185.70 Cr | — |
| Common Stock Payments | -2.90K Cr | -77.39 Cr | 0.00 | -185.70 Cr | — |
| Net Issuance Payments Of Debt | -1.03K Cr | -3.39K Cr | 5.13K Cr | -2.64K Cr | — |
| Net Short Term Debt Issuance | -48.20 Cr | 143.01 Cr | -130.49 Cr | 106.42 Cr | — |
| Net Long Term Debt Issuance | -982.14 Cr | -3.53K Cr | 5.26K Cr | -2.74K Cr | — |
| Long Term Debt Payments | -4.34K Cr | -8.11K Cr | -2.90K Cr | -4.40K Cr | — |
| Long Term Debt Issuance | 3.36K Cr | 4.57K Cr | 8.16K Cr | 1.66K Cr | — |
| Investing Cash Flow | -5.31K Cr | -690.20 Cr | -7.94K Cr | -5.72K Cr | — |
| Interest Received Cfi | 803.75 Cr | 613.20 Cr | 317.93 Cr | 76.30 Cr | — |
| Dividends Received Cfi | 66.02 Cr | 99.14 Cr | 132.40 Cr | 133.83 Cr | — |
| Net Investment Purchase And Sale | -3.82K Cr | 1.02K Cr | -1.49K Cr | -3.79K Cr | — |
| Sale Of Investment | 30.65K Cr | 31.59K Cr | 21.05K Cr | 20.87K Cr | — |
| Purchase Of Investment | -34.47K Cr | -30.57K Cr | -22.53K Cr | -24.66K Cr | — |
| Net Business Purchase And Sale | -318.33 Cr | -229.91 Cr | -4.84K Cr | -715.73 Cr | — |
| Sale Of Business | 0.00 | 0.00 | 0.00 | 23.84 Cr | — |
| Purchase Of Business | -318.33 Cr | -229.91 Cr | -4.84K Cr | -739.57 Cr | — |
| Net PPE Purchase And Sale | -2.07K Cr | -2.17K Cr | -2.06K Cr | -1.43K Cr | — |
| Sale Of PPE | 61.01 Cr | 30.84 Cr | 21.01 Cr | 60.61 Cr | — |
| Purchase Of PPE | -2.13K Cr | -2.20K Cr | -2.09K Cr | -1.50K Cr | — |
| Operating Cash Flow | 14.07K Cr | 12.13K Cr | 4.96K Cr | 8.98K Cr | — |
| Taxes Refund Paid | -476.84 Cr | -1.57K Cr | -1.51K Cr | 969.22 Cr | — |
| Change In Working Capital | -323.56 Cr | 1.06K Cr | -5.66K Cr | 1.56K Cr | — |
| Change In Other Current Liabilities | 182.03 Cr | 240.92 Cr | -669.15 Cr | -2.33K Cr | — |
| Change In Other Current Assets | -59.32 Cr | -383.90 Cr | -215.81 Cr | 14.11 Cr | — |
| Change In Payable | 527.97 Cr | 249.72 Cr | 1.18K Cr | 369.92 Cr | — |
| Change In Inventory | -183.97 Cr | 598.81 Cr | -1.20K Cr | 306.95 Cr | — |
| Change In Receivables | -1.60K Cr | 352.89 Cr | -953.17 Cr | -1.34K Cr | — |
| Other Non Cash Items | -1.00K Cr | -813.65 Cr | -227.61 Cr | -432.00 Cr | — |
| Provisionand Write Offof Assets | 180.83 Cr | 90.59 Cr | 207.05 Cr | 17.57 Cr | — |
| Depreciation And Amortization | 2.58K Cr | 2.56K Cr | 2.53K Cr | 2.14K Cr | — |
| Amortization Cash Flow | 1.23K Cr | 1.18K Cr | 1.26K Cr | — | — |
| Depreciation | 1.35K Cr | 1.38K Cr | 1.27K Cr | 2.14K Cr | — |
| Gain Loss On Investment Securities | -613.63 Cr | -195.49 Cr | -145.83 Cr | 97.24 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -336.67 Cr | -249.92 Cr | 336.81 Cr | -17.20 Cr | — |
| Gain Loss On Sale Of PPE | 1.78 Cr | 166.23 Cr | 22.71 Cr | 165.60 Cr | — |
| Gain Loss On Sale Of Business | 21.75 Cr | 0.00 | — | — | — |
| Net Income From Continuing Operations | 13.75K Cr | 11.09K Cr | 9.41K Cr | 4.48K Cr | — |
| Net Other Financing Charges | — | — | — | — | 425.00 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Sun Pharmaceutical Industries Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.